Share this video  

GU Cancers 2020 | Brant Inman: ASCO GU highlights

Brant Inman, MD, MS, Duke University Medical Center, Durham, NC, discusses his personal highlights from this year’s meeting. Specifically, he mentions combining enfortumab vedotin and pembrolizumab in patients with metastatic bladder cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.